MA26558A1 - Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant. - Google Patents
Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.Info
- Publication number
- MA26558A1 MA26558A1 MA25314A MA25314A MA26558A1 MA 26558 A1 MA26558 A1 MA 26558A1 MA 25314 A MA25314 A MA 25314A MA 25314 A MA25314 A MA 25314A MA 26558 A1 MA26558 A1 MA 26558A1
- Authority
- MA
- Morocco
- Prior art keywords
- methylerythromycin
- derivatives
- novel
- preparation
- pharmaceutical compositions
- Prior art date
Links
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6367697P | 1997-10-29 | 1997-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA26558A1 true MA26558A1 (fr) | 2004-12-20 |
Family
ID=22050768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA25314A MA26558A1 (fr) | 1997-10-29 | 1998-10-26 | Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6159945A (fr) |
| AP (1) | AP9801378A0 (fr) |
| AR (1) | AR017177A1 (fr) |
| AU (1) | AU9277698A (fr) |
| CO (1) | CO4810375A1 (fr) |
| GT (1) | GT199800163A (fr) |
| HN (1) | HN1998000159A (fr) |
| HR (1) | HRP980571A2 (fr) |
| MA (1) | MA26558A1 (fr) |
| PA (1) | PA8461701A1 (fr) |
| PE (1) | PE122499A1 (fr) |
| TN (1) | TNSN98194A1 (fr) |
| WO (1) | WO1999021866A1 (fr) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6710033B1 (en) | 1996-08-14 | 2004-03-23 | Vanderbilt University | Methods and treatment of multiple sclerosis |
| US6890526B2 (en) | 1997-05-06 | 2005-05-10 | Vanderbilt University | Methods and reagents for the treatment of multiple sclerosis |
| AP9801420A0 (en) * | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
| US6248719B1 (en) | 1998-06-03 | 2001-06-19 | Pfizer Inc | Tricyclic 3-keto derivatives of 6-O-methylerthromycin |
| EP1298138B1 (fr) * | 1998-12-10 | 2006-11-02 | Pfizer Products Inc. | Dérivés anitiobiotiques de Carbamate et de Carbazate Kètolides |
| DE69933897T2 (de) | 1998-12-10 | 2007-03-15 | Pfizer Products Inc., Groton | Carbamat- und Carbazatketolid-Antibiotika |
| CA2359708C (fr) | 1999-01-27 | 2005-10-25 | Pfizer Products Inc. | Antibiotiques cetolides |
| HUP0201516A3 (en) * | 1999-05-24 | 2003-03-28 | Pfizer Prod Inc | 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them |
| ID27331A (id) * | 1999-09-29 | 2001-03-29 | Pfizer Prod Inc | Pembuatan antibiotik-antibiotik ketolida karbamat |
| US6498146B1 (en) * | 1999-10-28 | 2002-12-24 | Pfizer Inc | Erythromycin derivatives |
| EP1146051A3 (fr) * | 2000-04-10 | 2001-10-31 | Pfizer Products Inc. | Dérivées de l' érythromycine A |
| US20020115621A1 (en) * | 2000-08-07 | 2002-08-22 | Wei-Gu Su | Macrolide antibiotics |
| US20040151765A1 (en) * | 2001-09-18 | 2004-08-05 | Ritchie Branson W. | Methods and compositions for wound management |
| US20040208842A1 (en) * | 2001-09-18 | 2004-10-21 | Ritchie Branson W. | Antimicrobial cleansing compositions and methods of use |
| US20070003508A1 (en) | 2005-07-01 | 2007-01-04 | Wooley Richard E | Methods and compositions for promoting wound healing |
| EP1638549A4 (fr) | 2003-03-10 | 2011-06-15 | Optimer Pharmaceuticals Inc | Nouveaux agents antibacteriens |
| US20070185202A1 (en) * | 2004-03-03 | 2007-08-09 | University Of Georgia Research Foundation, Inc. | Methods and compositions for ophthalmic treatment of fungal and bacterial infections |
| UA85937C2 (uk) | 2004-12-21 | 2009-03-10 | Пфайзер Продактс Інк. | Макроліди |
| EP2214484A4 (fr) | 2007-10-25 | 2013-01-02 | Cempra Pharmaceuticals Inc | Procédé pour la préparation d'agents antibactériens macrolides |
| JP5711135B2 (ja) | 2008-10-24 | 2015-04-30 | センプラ ファーマシューティカルズ，インコーポレイテッド | 胃腸疾患を治療するための方法 |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| ES2608285T3 (es) | 2009-09-10 | 2017-04-07 | Cempra Pharmaceuticals, Inc. | Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC |
| MX361413B (es) | 2010-03-22 | 2018-12-05 | Cempra Pharmaceuticals Inc Star | Formas cristalinas de un macrólido y usos para las mismas. |
| CN102917708B (zh) | 2010-05-20 | 2015-11-25 | 森普拉制药公司 | 制备大环内酯和酮内酯及其中间体的方法 |
| EP2613630A4 (fr) | 2010-09-10 | 2014-01-15 | Cempra Pharmaceuticals Inc | Fluorocétolides formant des liaisons hydrogène pour traiter les maladies |
| NZ700182A (en) | 2012-03-27 | 2017-02-24 | Cempra Pharmaceuticals Inc | Parenteral formulations for administering macrolide antibiotics |
| AU2014239959A1 (en) | 2013-03-14 | 2015-10-01 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| CN105188712A (zh) | 2013-03-15 | 2015-12-23 | 森普拉制药公司 | 用于制备大环内酯抗菌剂的收敛方法 |
| JP6437523B2 (ja) | 2013-04-04 | 2018-12-12 | プレジデント アンド フェローズ オブ ハーバード カレッジ | マクロライドならびにそれらの調製および使用の方法 |
| CN106998685A (zh) | 2014-10-08 | 2017-08-01 | 哈佛大学的校长及成员们 | 14‑元酮内酯及其制备和使用方法 |
| EP3273969A4 (fr) | 2015-03-25 | 2018-11-21 | President and Fellows of Harvard College | Macrolides à sucres modifiés de type désosamine et utilisations de ceux-ci |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL99995A (en) * | 1990-11-21 | 1997-11-20 | Roussel Uclaf | Erythromycin derivatives, their preparation and pharmaceutical compositions containing them |
| US6060234A (en) * | 1991-01-17 | 2000-05-09 | Abbott Laboratories | Polyketide derivatives and recombinant methods for making same |
| ATE135707T1 (de) * | 1992-04-22 | 1996-04-15 | Taisho Pharmaceutical Co Ltd | 5-0-desosaminylerythronolid a derivate |
| WO1998051696A1 (fr) * | 1997-05-09 | 1998-11-19 | Pfizer Products Inc. | Derives d'erythromycine |
| EP0988308A1 (fr) * | 1997-06-11 | 2000-03-29 | Pfizer Products Inc. | Derives de 9-oxime erythromycine |
-
1998
- 1998-10-08 HN HN1998000159A patent/HN1998000159A/es unknown
- 1998-10-09 WO PCT/IB1998/001578 patent/WO1999021866A1/fr not_active Ceased
- 1998-10-09 AU AU92776/98A patent/AU9277698A/en not_active Abandoned
- 1998-10-09 US US09/402,338 patent/US6159945A/en not_active Expired - Fee Related
- 1998-10-16 PA PA19988461701A patent/PA8461701A1/es unknown
- 1998-10-22 PE PE1998000993A patent/PE122499A1/es not_active Application Discontinuation
- 1998-10-23 GT GT199800163A patent/GT199800163A/es unknown
- 1998-10-26 MA MA25314A patent/MA26558A1/fr unknown
- 1998-10-26 TN TNTNSN98194A patent/TNSN98194A1/fr unknown
- 1998-10-27 AR ARP980105379A patent/AR017177A1/es not_active Application Discontinuation
- 1998-10-29 AP APAP/P/1998/001378A patent/AP9801378A0/en unknown
- 1998-10-29 HR HR60/063,676A patent/HRP980571A2/hr not_active Application Discontinuation
- 1998-10-29 CO CO98063687A patent/CO4810375A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP980571A2 (en) | 1999-08-31 |
| HN1998000159A (es) | 1999-02-09 |
| PE122499A1 (es) | 1999-12-02 |
| PA8461701A1 (es) | 2000-05-24 |
| AR017177A1 (es) | 2001-08-22 |
| AP9801378A0 (en) | 2000-04-29 |
| TNSN98194A1 (fr) | 2005-03-15 |
| CO4810375A1 (es) | 1999-06-30 |
| WO1999021866A1 (fr) | 1999-05-06 |
| GT199800163A (es) | 2000-04-15 |
| US6159945A (en) | 2000-12-12 |
| AU9277698A (en) | 1999-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA26558A1 (fr) | Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| MA26472A1 (fr) | Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| MA26424A1 (fr) | Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| MA26680A1 (fr) | Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26686A1 (fr) | Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26468A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26414A1 (fr) | Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant. | |
| MA26479A1 (fr) | Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26499A1 (fr) | Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant . | |
| MA26433A1 (fr) | Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| FR2780057B1 (fr) | Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26425A1 (fr) | Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26505A1 (fr) | Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26438A1 (fr) | Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| MA26465A1 (fr) | Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26432A1 (fr) | Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| MA26471A1 (fr) | Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| MA26490A1 (fr) | Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant. | |
| MA26687A1 (fr) | 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26614A1 (fr) | Bicyclo [2.2.1] heptanes nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| FR2735777B1 (fr) | Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant | |
| MA26740A1 (fr) | Derives de 13-methyl-erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26508A1 (fr) | Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation. | |
| MA26559A1 (fr) | Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation | |
| MA26519A1 (fr) | Derives d'azetidinylpropylpiperidine, procede pour leur preparation et compositions pharmaceutiques les contenant. |